Company: IPSC
Filing Date: 2025-08-29
Form Type: 8-K
Source: 0001104659-25-085658
Chunk: 0

Company: Century Therapeutics, Inc.
Filing Date: 2025-08-29
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01      Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.  

On February 26, 2025, Century Therapeutics, Inc. (the
“ Company”) received a deficiency letter from the Nasdaq Listing
Qualifications Staff (“ Staff”) of The Nasdaq Stock Market LLC
(“ Nasdaq”) notifying the Company that based on the closing bid price for
the last 30 consecutive business days, the Company was not in compliance with the $1.00 minimum bid price requirement for continued
listing on The Nasdaq Global Select Market, as set forth in Nasdaq Listing Rule 5450(a)(1) (the “ Bid
Price Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided a period of 180
calendar days, or until August 26, 2025 (the “ Initial Compliance Date”),
to regain compliance with the Bid Price Rule.

The Company did not regain compliance with the Bid Price Rule by
the Initial Compliance Date. On August 27, 2025, Nasdaq notified the Company that it had granted the Company an additional 180 calendar
day period, or until February 23, 2026 (the “ Extended Compliance Date”), to regain compliance with the Bid Price Rule.
Nasdaq’s determination was based on, among other things, (1) the Company meeting the continued listing requirement for market
value of publicly held shares and all other initial listing requirements for The Nasdaq Capital Market, with the exception of the Bid
Price Rule, and (2) the Company’s written notice of its intention to cure the deficiency by effecting a reverse stock split,
if necessary. On August 27, 2025, Nasdaq approved the Company’s transfer from The Nasdaq Global Select Market to The Nasdaq Capital
Market. This transfer became effective at the opening of business on August 27, 202 and the Company’s common stock continues to
trade under the symbol “ IPSC.” The Nasdaq Capital Market is a continuous trading market that operates in substantially the
same manner as The Nasdaq Global Select Market, and listed companies must meet certain financial requirements and comply with Nasdaq’s
corporate governance requirements.

If, at any time before the Extended Compliance Date, the closing bid
price for the Company’s common stock is at least $1.00 per share for a minimum of 10 consecutive business days as required under
the